Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.23832 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Xuyue Liu and 9 co-authors. Institution: Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Ch…. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Autophagy, Protein Glutamine gamma Glutamyltransferase 2. Cited 1 times so far (Crossref); 51 references. Funded by: This work was supported by National Natural Science Foundation of China (Grant numbers 81874118), Joint funds of Natural Science Foundation of Shandong Provinc…, National Natural Science Foundation of China.
Abstract (original language)
Liver cancer is the third leading cause of cancer‐related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for 85% of liver cancer‐related deaths. Autophagy controls HCC cell growth, invasion, metastasis, drug resistance, and stemness. Spermatogenesis and oogenesis basic helix‐loop‐helix transcription factor 2 (Sohlh2) can bind to the E‐boxes in the promoter regions of target genes, which are involved in multiple neoplasms. In this study, Sohlh2 was highly expressed in HCC tissues and was related to poor prognosis. Moreover, Sohlh2 overexpression promoted the proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. However, Sohlh2 silencing inhibited proliferation, migration, invasion, and metastasis of HCC cells in vivo and in vitro. Mechanistically, Sohlh2 could bind to the promoter of TGM2 and enhance its transcriptional activity, thereby enhancing the autophagy of HCC cells. Furthermore, Sohlh2 protein levels were positively associated with TGM2 expression in HCC tissues. Taken together, these results demonstrate that Sohlh2 can promote HCC progression via TGM2‐mediated autophagy, implying that Sohlh2 is a promising candidate for HCC treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of The Ministry of Education for Experimental Teratology, Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Research Center for Medical and Structural Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Liver Transplantation Center, Clinical Research Center for Pediatric Liver Transplantation, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, Chi…
ORCID profiles: Xuyue Liu, Yanru Chen, Jing Hao
Funding
- This work was supported by National Natural Science Foundation of China (Grant numbers 81874118), Joint funds of Natural Science Foundation of Shandong Provinc…
- National Natural Science Foundation of China
Cite
APA
Liu, X., Zhang, R., Liu, L., Zhi, S., Feng, X., Shen, Y., Wang, L., Zhang, Q., Chen, Y., & Hao, J. (2025). Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23832
Vancouver
Liu X, Zhang R, Liu L, Zhi S, Feng X, Shen Y, et al. Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23832
BibTeX
@article{Liu2025,
author = {Liu, Xuyue and Zhang, Ruihong and Liu, Lanlan and Zhi, Sujuan and Feng, Xiaoning and Shen, Ying and Wang, Liyan and Zhang, Qi and Chen, Yanru and Hao, Jing},
title = {Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.23832}
}
EUVIMED